SCHEMBL14447191

SCHEMBL14447191

Cc1c(Cl)[nH]c2c1Cc1ccccc1-2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.53
CA2 P00918 8/20 0.53
CA4 P22748 8/20 0.53
CA6 P23280 8/20 0.53
KDR P35968 2/20 0.41
EIF2AK1 Q9BQI3 1/20 0.40
PLK4 O00444 1/20 0.39
DAPK3 O43293 1/20 0.39
PIM1 P11309 1/20 0.39
PDGFRA P16234 1/20 0.39
LTK P29376 1/20 0.39
MAP2K2 P36507 1/20 0.39
FLT3 P36888 1/20 0.39
MAPK8 P45983 1/20 0.39
MAPK9 P45984 1/20 0.39
CSNK1A1 P48729 1/20 0.39
TDO2 P48775 1/20 0.39
CDK8 P49336 1/20 0.39
CDK5 Q00535 1/20 0.39
MAP2K1 Q02750 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9526530 0.72 CCNB2 (0.63) CA1CA2CA4CA6EIF2AK1
SCHEMBL23833551 0.69 GABRP (0.46) CA1CA2CA4CA6CDK1
SCHEMBL2298597 0.69 CA1 (1.00) CA1CA2CA4CA6CDK5
SCHEMBL29370925 0.69 CA1 (1.00) CA1CA2CA4CA6CDK5
SCHEMBL29834173 0.68 CA1 (0.47) CA1CA2CA4CA6KDR
SCHEMBL23649412 0.68 CA1 (0.47) CA1CA2CA4CA6KDR
SCHEMBL9531089 0.68 CA1 (0.71) CA1CA2CA4CA6CDK5
SCHEMBL12382594 0.68 CA1 (0.69) CA1CA2CA4CA6CDK5
SCHEMBL4627835 0.68 CA1 (0.69) CA1CA2CA4CA6CDK5
SCHEMBL9527328 0.67 CA1 (0.50) CA1CA2CA4CA6KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173535-A1 Oxadiazoles having antiproliferative activity SASSARI, UNIVERSITA' DEGLISTUDI DI (IT) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173535-A1 Oxadiazoles having antiproliferative activity MKI67, OXA1L, TOP1 CA1 2771/4885CA2 2162/4885CA4 2819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.